Results 91 to 100 of about 45,096 (205)

In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment

open access: yesMolecules
The burden of human schistosomiasis, a known but neglected tropical disease in Sub-Saharan Africa, has been worrisome in recent years. It is becoming increasingly difficult to tackle schistosomiasis with praziquantel, a drug known to be effective against
Babatunji Emmanuel Oyinloye   +12 more
doaj   +1 more source

Pharmacophore results plot.

open access: yes, 2015
5 feature pharmacophore lab set (black x), 5 feature pharmacophore literature set (green circle), 5 featured combined set (magenta plus), 6 feature pharmacophore lab set (red circle), 6 feature pharmacophore literature set (cyan box) and 6 featured ...
Leo van Buren (550041)   +6 more
core   +1 more source

Structure-based pharmacophore construction general outline.

open access: yes, 2012
The interactions are translated into pharmacophore features while the binding site amino acids are translated into excluded volumes. The shape of the binding site is also added to increase sensitivity of the pharmacophore.
Eman M. Dokla (118484)   +5 more
core   +1 more source

3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole–benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2017
A 3D-QSAR modeling was performed on a series of diarylpyrazole-benzenesulfonamide derivatives acting as inhibitors of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).
Yeganeh Entezari Heravi   +5 more
doaj   +1 more source

Pharmacophore model and aligned ligands.

open access: yes, 2018
The pharmacophore model of IGF-1R inhibitors are generated by MOE module with set of aligned active compounds. Pharmacophore model was generated with three chemical features such as aromatic hydrophobic (HyD/Aro); hydrophobic (HyD) and hydrogen bond ...
Rumeza Hanif (5249699)   +4 more
core   +1 more source

Special Issue: Chemoinformatics

open access: yesMolecules, 2016
Chemoinformatics techniques were originally developed for the construction and searching of large archives of chemical structures but they were soon applied to problems in drug discovery and are now playing an increasingly important role in many ...
Peter Willett
doaj   +1 more source

Synthesis and Sar Study of Diarylpentanoid Analogues as New Anti-Inflammatory Agents

open access: yesMolecules, 2014
A series of ninety-seven diarylpentanoid derivatives were synthesized and evaluated for their anti-inflammatory activity through NO suppression assay using interferone gamma (IFN-γ)/lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages.
Sze Wei Leong   +10 more
doaj   +1 more source

Ebola active cpds pharmacophore

open access: yes, 2014
Discovery Studio pharmacophore (common features) developed for compounds active vs ...
Sean Ekins (97122)
core   +1 more source

Pharmacophore features.

open access: yes, 2018
Pharmacophore features are defined as orange, green and purple colored represented by F1-aromatic hydrophobic (HyD/Aro), F2-hydrophobic (HyD) and F3-hydrogen bond acceptor (HBA).
Rumeza Hanif (5249699)   +4 more
core   +1 more source

Ligand-based pharmacophore modeling using novel 3D pharmacophore signatures

open access: yes, 2020
© 2018 by the authors. Pharmacophore modeling is a widely used strategy for finding new hit molecules. Since not all protein targets have available 3D structures, ligand-based approaches are still useful. Currently, there are just a few free ligand-based
Kutlushina A.   +3 more
core  

Home - About - Disclaimer - Privacy